For decades, Johnson’s Baby Powder was one of the most trusted household products in the world. Many families used it on babies, while countless women also used talcum powder as part of their daily personal hygiene routine.
Now, that familiar white bottle is once again making headlines.
Johnson & Johnson (J&J) has announced that it is prepared to pay up to $5.5 billion to settle approximately 76,000 lawsuits in the United States. The lawsuits claim that the company’s talc-based products contributed to ovarian cancer in women who used them over many years.
The proposed agreement still requires support from lawyers representing at least 95% of the remaining ovarian cancer claimants before it can become final. Importantly, Johnson & Johnson continues to deny that its products caused cancer, saying the settlement is intended to end years of expensive litigation rather than admit wrongdoing.
So, what exactly happened? Why have these lawsuits lasted for more than a decade? And should today’s consumers still be worried?
Let’s break it down.
Image credit: Photo by Nataliya Vaitkevich on Pexels
Editor’s Note
This article summarizes current legal developments and publicly available scientific evidence. The proposed settlement does not represent an admission of liability by Johnson & Johnson, and scientific research on talc and ovarian cancer remains under discussion.
Why Is Johnson & Johnson Paying Billions?
At first glance, it may sound like Johnson & Johnson has admitted its baby powder caused cancer.
That isn’t what happened.
The company has consistently maintained that its talc products are safe, asbestos-free, and backed by decades of scientific testing. Even while announcing the proposed settlement, J&J repeated that the allegations against it are “without merit.”
According to Erik Haas, Vice President of Litigation at Johnson & Johnson, resolving the lawsuits allows the company to move forward and focus on developing medicines and medical technologies instead of continuing years of courtroom battles.
For many large companies, settlements are sometimes viewed as a practical business decision. Continuing thousands of individual trials across different states can take years, cost billions of dollars in legal fees, and produce unpredictable verdicts.
That doesn’t automatically mean the company agrees with the claims being made against it.
How Did This Controversy Begin?
The controversy dates back more than 15 years.
Around 2009, women across the United States began filing lawsuits claiming they had developed ovarian cancer after regularly using Johnson’s Baby Powder or other talc-based products for feminine hygiene over many years.
Most of these women said they had applied the powder around the genital area, believing it helped them stay dry and comfortable.
Their lawsuits raised two major arguments.
The first claim was that tiny talc particles could travel through the female reproductive tract, eventually reaching the ovaries and contributing to long-term inflammation that might increase cancer risk.
The second claim received even more attention.
Some plaintiffs argued that certain talc products were contaminated with asbestos, a naturally occurring mineral known to cause cancer. Because talc and asbestos can sometimes be found close together underground, critics argued that contamination could occur during mining unless carefully prevented.
Johnson & Johnson has repeatedly rejected these claims, saying its cosmetic talc was carefully tested and did not contain asbestos.
Why Did So Many Women Decide to Sue?
As more women learned about the lawsuits, thousands began asking the same question:
“Could my cancer have been linked to something I used almost every day?”
That question led to one of the largest product liability cases in U.S. history.
Some juries awarded substantial compensation to women and their families. Other courts ruled in Johnson & Johnson’s favor or reduced earlier verdicts on appeal.
This is one reason the story has often seemed confusing.
Depending on which court case people read about, the headlines could look completely different.
One jury might conclude there was enough evidence to support a plaintiff’s claim, while another court could determine that the available scientific evidence was not strong enough to prove that talc caused a specific woman’s cancer.
Rather than producing one clear legal answer, the litigation created years of conflicting outcomes.
The Science Turned Out to Be More Complicated Than Many Headlines Suggested
One reason these lawsuits have continued for so long is that science has not produced one simple answer.
Some observational studies have suggested a small increase in ovarian cancer risk among women who reported long-term genital use of talcum powder.
Other well-designed studies have found little or no significant association.
Researchers also point out that ovarian cancer is a complex disease influenced by many factors, including genetics, age, reproductive history, hormone exposure, obesity, and family history.
That makes it extremely difficult to determine whether one product alone caused an individual person’s cancer.
Because of these uncertainties, much of the courtroom debate has focused not only on the products themselves, but also on whether experts can reliably prove that talc caused cancer in a specific individual.
That scientific debate continues today, even as the legal cases move toward a possible settlement.
Why Johnson & Johnson Stopped Selling Talc Baby Powder
One of the biggest misconceptions about this case is that Johnson & Johnson removed its talc-based baby powder from the market because it admitted the product was dangerous.
That isn’t what the company has said.
In 2020, J&J stopped selling talc-based Johnson’s Baby Powder in the United States and Canada, citing declining demand and what it described as widespread “misinformation” surrounding the product. The company continued to insist that decades of testing supported the safety of its cosmetic talc.
Then, in 2022, the company announced an even bigger change.
It would stop selling talc-based baby powder worldwide and replace it with a cornstarch-based formula. Today, the familiar Johnson’s Baby Powder sold in most countries is made with cornstarch rather than talc.
For many consumers, this raised an obvious question:
“If the product was safe, why replace it?”
Johnson & Johnson says the decision reflected changing consumer preferences and years of legal disputes rather than concerns about product safety. Critics, however, argue that the move acknowledged growing public concern and reduced future legal risks.
Those different interpretations remain part of the ongoing debate.
The Company’s Unusual Legal Strategy
As thousands of lawsuits continued to grow, Johnson & Johnson looked for a way to resolve them all at once instead of fighting individual cases across the country.
The company created a separate subsidiary that assumed responsibility for the talc-related claims and then placed that subsidiary into bankruptcy.
This legal strategy became widely known as the “Texas Two-Step.”
The idea was to use bankruptcy proceedings to negotiate one large settlement that would cover both current and future claims.
However, U.S. courts rejected that approach multiple times.
Judges ruled that the subsidiary did not meet the legal requirements for bankruptcy protection because Johnson & Johnson itself remained one of the world’s strongest and most profitable healthcare companies. As a result, the lawsuits returned to the regular court system.
After those bankruptcy efforts failed, settlement negotiations resumed directly between the company and lawyers representing thousands of women.
Why Did Johnson & Johnson Choose to Settle Now?
Interestingly, the proposed settlement comes after several legal developments that appeared to strengthen Johnson & Johnson’s position.
Only days before the announcement, a federal judge questioned whether expert witnesses could reliably prove that talcum powder specifically caused ovarian cancer in individual women. The judge did not dismiss the lawsuits but signaled that plaintiffs would need stronger scientific evidence to continue many of the cases.
At the same time, Johnson & Johnson had won several recent trials, while other verdicts in favor of plaintiffs had been reduced or overturned on appeal.
So why settle?
According to the company, continuing thousands of individual lawsuits could take many more years, creating uncertainty for both the business and the families involved.
Erik Haas, Johnson & Johnson’s Vice President of Litigation, said the agreement would allow the company to “put this matter behind it” and remain focused on developing medicines and medical devices.
Lawyers representing many of the plaintiffs reached a different conclusion.
They said years of litigation had finally created an opportunity to obtain meaningful compensation for thousands of women and their families without forcing them to endure additional years of court proceedings.
What Does This Mean for Consumers Today?
If you’ve used Johnson’s Baby Powder in the past, headlines like these can understandably feel alarming.
However, it’s important to keep the situation in perspective.
First, the current settlement does not mean Johnson & Johnson has admitted its products caused cancer. The company continues to deny those allegations and says the agreement is intended to end years of costly litigation.
Second, today’s Johnson’s Baby Powder is not the same product that became the focus of these lawsuits.
The company no longer markets a talc-based version globally, having replaced it with a cornstarch-based formula.
Finally, ovarian cancer remains a complex disease with many known risk factors, including age, inherited genetic mutations such as BRCA1 and BRCA2, reproductive history, obesity, hormone exposure, and family history.
Scientists continue to study whether long-term genital use of talcum powder plays a role for some women, but the evidence has not produced one universally accepted answer.
That scientific uncertainty is one reason these lawsuits have remained controversial for so many years.
The Bottom Line
The Johnson & Johnson talc litigation has become one of the largest product liability cases in U.S. history.
What began as lawsuits filed by individual women eventually grew into tens of thousands of claims, years of courtroom battles, billions of dollars in verdicts and appeals, multiple failed bankruptcy attempts, and now a proposed settlement worth up to $5.5 billion.
Whether the agreement ultimately receives the required support from plaintiffs will determine if this chapter finally comes to an end.
For consumers, the biggest takeaway is this:
The settlement is not a scientific conclusion that talcum powder causes ovarian cancer. Instead, it is a legal agreement designed to resolve years of complex litigation while scientific research continues to evolve.
Understanding that distinction helps separate the courtroom arguments from the medical evidence—and allows women to make informed decisions based on facts rather than headlines.
Have you been following the Johnson & Johnson talc lawsuits, or did this story surprise you?
Share your thoughts in the comments below — do you think this settlement brings closure, or are there still important questions that need answers?